1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis
2019) In International Journal of Cardiology(
- Contribution to journal › Article
-
Mark
Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events
(
- Contribution to journal › Article
- 2017
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction
(
- Contribution to journal › Article
- 2015
-
Mark
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease : An analysis from the platelet inhibition and patient outcomes (plato) trial
(
- Contribution to journal › Article